Proton beam therapy for non-small cell lung cancer
HAYES, Inc
            Record ID 32017000177
            English
                                                            
                Authors' recommendations:
                Proton beam therapy (PBT) is a type of external radiation treatment in which positively charged subatomic particles (protons) are precisely targeted to a specific tissue mass using a sophisticated stereotaxic planning and delivery system. In comparison with conventional photon or electron irradiation, proton beam radiation may deliver a higher dose to the target tissue, while minimizing exposure to surrounding healthy tissue. Rationale: The physical properties of proton beams can be used to improve the targeting of radiation therapy relative to conventional photon or electron beam radiation therapy, potentially reducing the undesirable adverse events that can occur during and after radiation therapy for lung cancer, particularly, non-small cell lung cancer (NSCLC).
Controversy: Highly sophisticated methods have been developed for targeting conventional radiation therapy, including dose fractionation, modulation of radiation intensity, and delivery of radiation with devices that sweep in multiple arcs around the patient to generate beams that intersect at the tumor. As a result, the type and severity of complications of conventional lung radiation therapy are usually similar to those that occur during and after PBT. 
Relevant Questions: Compared with other treatment options, does PBT improve local control of the target lesion and/or increase survival for patients with NSCLC? Does PBT cause fewer complications than other types of radiation therapy? Have definitive patient selection criteria for PBT for NSCLC been established?
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2017
            
                                    
                URL for published report:
                The report may be purchased from:
http://www.hayesinc.com/hayes/crd/?crd=58066
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                United States
            
                                                
                        MeSH Terms
            - Carcinoma, Non-Small-Cell Lung
- Humans
- Lung Neoplasms
- Proton Therapy
- Protons
Contact
                        
                Organisation Name:
                HAYES, Inc.
            
            
                        
                Contact Address:
                157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
            
                                    
                Contact Name:
                saleinfo@hayesinc.com
            
                                    
                Contact Email:
                saleinfo@hayesinc.com
            
                                    
                Copyright:
                Winifred S. Hayes, Inc
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.